Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Gene-Modified Cell Therapy to Target CD7 for Oncology by Suzhou Fundamenta Therapeutics for T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
Gene-Modified Cell Therapy to Target CD7 for Oncology is under clinical development by Suzhou Fundamenta Therapeutics and currently in Phase...